Hyundai Bioscience announces XAFTY®, a groundbreaking broad-spectrum antiviral capable of treating COVID-19, mpox, and dengue

Hyundai Bioscience presents development updates of its broad-spectrum antiviral at the “Disease Prevention and Control Summit 2024” held in Philadelphia, USA. SEOUL, South Korea, Sept. 11, 2024 /PRNewswire/ — Dr. Heung-Jeong Woo, a vice president of Hyundai Bioscience shared insights on…